Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	procollagen-lysine 5-dioxygenase activity	PLOD3 PLOD1	3.32e-05	3	67	2	GO:0008475
GeneOntologyMolecularFunction	procollagen glucosyltransferase activity	PLOD3 PLOD1	3.32e-05	3	67	2	GO:0033823
GeneOntologyMolecularFunction	peptidyl-lysine 5-dioxygenase activity	PLOD3 PLOD1	6.63e-05	4	67	2	GO:0070815
GeneOntologyMolecularFunction	phosphorylase kinase activity	PHKA1 PHKA2	6.63e-05	4	67	2	GO:0004689
GeneOntologyMolecularFunction	DNA topoisomerase activity	TOP1 TOP2B	3.07e-04	8	67	2	GO:0003916
GeneOntologyMolecularFunction	nitrite reductase activity	CYGB MTARC2	5.98e-04	11	67	2	GO:0098809
GeneOntologyCellularComponent	septin complex	SEPTIN8 SEPTIN11 SEPTIN10	1.12e-05	14	67	3	GO:0031105
GeneOntologyCellularComponent	septin ring	SEPTIN8 SEPTIN11 SEPTIN10	1.12e-05	14	67	3	GO:0005940
GeneOntologyCellularComponent	septin cytoskeleton	SEPTIN8 SEPTIN11 SEPTIN10	1.71e-05	16	67	3	GO:0032156
GeneOntologyCellularComponent	tenascin complex	TNN TNR	6.05e-05	4	67	2	GO:0090733
GeneOntologyCellularComponent	phosphorylase kinase complex	PHKA1 PHKA2	1.01e-04	5	67	2	GO:0005964
MousePheno	decreased diameter of femur	COL12A1 CANT1 IL6ST	3.11e-05	16	55	3	MP:0008152
Domain	Septin	SEPTIN8 SEPTIN11 SEPTIN10	1.07e-05	13	64	3	PF00735
Domain	G_SEPTIN_dom	SEPTIN8 SEPTIN11 SEPTIN10	1.07e-05	13	64	3	IPR030379
Domain	G_SEPTIN	SEPTIN8 SEPTIN11 SEPTIN10	1.07e-05	13	64	3	PS51719
Domain	Tscrpt_reg_Wos2-domain	MYB MYBL1	1.16e-05	2	64	2	IPR012642
Domain	LMSTEN	MYB MYBL1	1.16e-05	2	64	2	PF07988
Domain	Septin	SEPTIN8 SEPTIN11 SEPTIN10	1.36e-05	14	64	3	IPR016491
Domain	fn3	COL12A1 LRRN1 NRCAM TNN TNR IL6ST	1.92e-05	162	64	6	PF00041
Domain	Glyco_hydro_15	PHKA1 PHKA2	3.46e-05	3	64	2	PF00723
Domain	Cmyb_C	MYB MYBL1	3.46e-05	3	64	2	PF09316
Domain	LYS_HYDROXYLASE	PLOD3 PLOD1	3.46e-05	3	64	2	PS01325
Domain	Glyco_hydro_15/PHK	PHKA1 PHKA2	3.46e-05	3	64	2	IPR011613
Domain	C-myb_C	MYB MYBL1	3.46e-05	3	64	2	IPR015395
Domain	PHK_A/B_su	PHKA1 PHKA2	3.46e-05	3	64	2	IPR008734
Domain	Procol_lys_dOase	PLOD3 PLOD1	3.46e-05	3	64	2	IPR001006
Domain	FN3	COL12A1 LRRN1 NRCAM TNN TNR IL6ST	4.05e-05	185	64	6	SM00060
Domain	FN3	COL12A1 LRRN1 NRCAM TNN TNR IL6ST	6.08e-05	199	64	6	PS50853
Domain	FN3_dom	COL12A1 LRRN1 NRCAM TNN TNR IL6ST	7.98e-05	209	64	6	IPR003961
Domain	EGF_3	TNN TLL1 HABP2 C8B TNR LRP1B	1.52e-04	235	64	6	PS50026
Domain	EGF-like_dom	TNN TLL1 HABP2 C8B TNR LRP1B	2.08e-04	249	64	6	IPR000742
Domain	EGF_1	TNN TLL1 HABP2 C8B TNR LRP1B	2.36e-04	255	64	6	PS00022
Domain	EGF-like_CS	TNN TLL1 HABP2 C8B TNR LRP1B	2.67e-04	261	64	6	IPR013032
Domain	EGF_2	TNN TLL1 HABP2 C8B TNR LRP1B	2.90e-04	265	64	6	PS01186
Domain	6hp_glycosidase	PHKA1 PHKA2	3.19e-04	8	64	2	IPR012341
Domain	-	PHKA1 PHKA2	3.19e-04	8	64	2	1.50.10.10
Domain	HTH_MYB	MYB MYBL1	4.10e-04	9	64	2	PS51294
Domain	Myb_dom	MYB MYBL1	4.10e-04	9	64	2	IPR017930
Domain	6-hairpin_glycosidase-like	PHKA1 PHKA2	8.80e-04	13	64	2	IPR008928
Domain	EGF_extracell	TNN TNR LRP1B	1.14e-03	60	64	3	IPR013111
Domain	EGF_2	TNN TNR LRP1B	1.14e-03	60	64	3	PF07974
Domain	EGF	TNN TLL1 HABP2 TNR LRP1B	1.26e-03	235	64	5	SM00181
Domain	P4Hc	PLOD3 PLOD1	1.34e-03	16	64	2	SM00702
Domain	Pro_4_hyd_alph	PLOD3 PLOD1	1.34e-03	16	64	2	IPR006620
Domain	2OG-FeII_Oxy	PLOD3 PLOD1	1.90e-03	19	64	2	PF03171
Domain	FE2OG_OXY	PLOD3 PLOD1	2.33e-03	21	64	2	PS51471
Domain	Oxoglu/Fe-dep_dioxygenase	PLOD3 PLOD1	2.79e-03	23	64	2	IPR005123
Domain	VWFA	CPNE8 COL12A1 ITIH5	2.80e-03	82	64	3	PS50234
Domain	VWA	CPNE8 COL12A1 ITIH5	3.00e-03	84	64	3	SM00327
Domain	Fibrinogen_a/b/g_C_2	TNN TNR	3.04e-03	24	64	2	IPR014715
Domain	-	TNN TNR	3.04e-03	24	64	2	4.10.530.10
Domain	TUDOR	TDRD7 PHF19	3.84e-03	27	64	2	SM00333
Domain	Fibrinogen_C	TNN TNR	3.84e-03	27	64	2	PF00147
Domain	FBG	TNN TNR	4.42e-03	29	64	2	SM00186
Domain	Tudor	TDRD7 PHF19	4.73e-03	30	64	2	IPR002999
Domain	-	TNN TNR	4.73e-03	30	64	2	3.90.215.10
Domain	Fibrinogen_a/b/g_C_1	TNN TNR	4.73e-03	30	64	2	IPR014716
Domain	VWF_A	CPNE8 COL12A1 ITIH5	4.76e-03	99	64	3	IPR002035
Domain	FIBRINOGEN_C_1	TNN TNR	5.37e-03	32	64	2	PS00514
Domain	Fibrinogen_a/b/g_C_dom	TNN TNR	5.37e-03	32	64	2	IPR002181
Domain	FIBRINOGEN_C_2	TNN TNR	5.37e-03	32	64	2	PS51406
Domain	Myb_DNA-binding	MYB MYBL1	6.39e-03	35	64	2	PF00249
Pathway	REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS	PHKA1 PHKA2 PYGL	1.58e-05	14	51	3	MM15391
Pathway	REACTOME_GLYCOGEN_BREAKDOWN_GLYCOGENOLYSIS	PHKA1 PHKA2 PYGL	1.58e-05	14	51	3	M19193
Pathway	REACTOME_GLYCOGEN_METABOLISM	PHKA1 PHKA2 PYGL	3.50e-05	18	51	3	MM15577
Pathway	REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES	COL12A1 PLOD3 TLL1 PLOD1	6.81e-05	61	51	4	MM14637
Pathway	REACTOME_GLYCOGEN_METABOLISM	PHKA1 PHKA2 PYGL	9.70e-05	25	51	3	M27857
Pathway	REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES	COL12A1 PLOD3 TLL1 PLOD1	9.84e-05	67	51	4	M26999
Pathway	REACTOME_COLLAGEN_FORMATION	COL12A1 PLOD3 TLL1 PLOD1	1.61e-04	76	51	4	MM14573
Pathway	WP_GLYCOGEN_METABOLISM	PHKA1 PHKA2 PYGL	2.47e-04	34	51	3	MM15985
Pathway	REACTOME_COLLAGEN_FORMATION	COL12A1 PLOD3 TLL1 PLOD1	3.09e-04	90	51	4	M631
Pathway	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	COL12A1 PLOD3 TNN TLL1 PLOD1 TNR	3.20e-04	258	51	6	MM14572
Pathway	WP_GLYCOGEN_SYNTHESIS_AND_DEGRADATION	PHKA1 PHKA2 PYGL	4.01e-04	40	51	3	M39595
Pathway	REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION	COL12A1 PLOD3 TNN TLL1 PLOD1 TNR	7.11e-04	300	51	6	M610
Pubmed	Adenoid cystic carcinoma of the Bartholin's gland is underpinned by MYB- and MYBL1- rearrangements.	MYB MYBL1	3.66e-06	2	67	2	38368814
Pubmed	Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course.	MYB MYBL1	3.66e-06	2	67	2	31563982
Pubmed	Effects of cinobufacini injection on cell proliferation and the expression of topoisomerases in human HepG-2 hepatocellular carcinoma cells.	TOP1 TOP2B	3.66e-06	2	67	2	25815590
Pubmed	X-linked liver glycogenosis type II (XLG II) is caused by mutations in PHKA2, the gene encoding the liver alpha subunit of phosphorylase kinase.	PHKA1 PHKA2	3.66e-06	2	67	2	8733133
Pubmed	Cloning and characterization of a third human lysyl hydroxylase isoform.	PLOD3 PLOD1	3.66e-06	2	67	2	9724729
Pubmed	Inhibitory effect of conjugated eicosapentaenoic acid on human DNA topoisomerases I and II.	TOP1 TOP2B	3.66e-06	2	67	2	15680922
Pubmed	The multiphosphorylation domain of the phosphorylase kinase alpha M and alpha L subunits is a hotspot of differential mRNA processing and of molecular evolution.	PHKA1 PHKA2	3.66e-06	2	67	2	8226841
Pubmed	Characterization of a cancer-associated Epstein-Barr virus EBNA1 variant reveals a novel interaction with PLOD1 and PLOD3.	PLOD3 PLOD1	3.66e-06	2	67	2	34304093
Pubmed	Expression of mouse c-myb during embryonic development.	MYB MYBL1	3.66e-06	2	67	2	8570177
Pubmed	Pediatric-type diffuse low-grade glioma with MYB/MYBL1 alteration: report of 2 cases.	MYB MYBL1	3.66e-06	2	67	2	36074655
Pubmed	Arrest of spermatogenesis and defective breast development in mice lacking A-myb.	MYB MYBL1	3.66e-06	2	67	2	9109487
Pubmed	MYB and MYBL1 in adenoid cystic carcinoma: diversity in the mode of genomic rearrangement and transcripts.	MYB MYBL1	3.66e-06	2	67	2	29410490
Pubmed	A single-center study of the clinicopathologic correlates of gliomas with a MYB or MYBL1 alteration.	MYB MYBL1	3.66e-06	2	67	2	31595312
Pubmed	cDNA cloning of a liver isoform of the phosphorylase kinase alpha subunit and mapping of the gene to Xp22.2-p22.1, the region of human X-linked liver glycogenosis.	PHKA1 PHKA2	3.66e-06	2	67	2	1372435
Pubmed	DNA binding and transactivation activity of A-myb, a c-myb-related gene.	MYB MYBL1	3.66e-06	2	67	2	7987850
Pubmed	Detecting MYB and MYBL1 fusion genes in tracheobronchial adenoid cystic carcinoma by targeted RNA-sequencing.	MYB MYBL1	3.66e-06	2	67	2	31028361
Pubmed	Localization of septin proteins in the mouse cochlea.	SEPTIN8 SEPTIN11 SEPTIN10	3.76e-06	16	67	3	22575789
Pubmed	Androglobin, a chimeric mammalian globin, is required for male fertility.	SEPTIN8 SEPTIN11 SEPTIN10	6.48e-06	19	67	3	35700329
Pubmed	Procollagen-lysine, 2-oxoglutarate 5-dioxygenases 1, 2, and 3 are potential prognostic indicators in patients with clear cell renal cell carcinoma.	PLOD3 PLOD1	1.10e-05	3	67	2	31446433
Pubmed	The myb gene family in cell growth, differentiation and apoptosis.	MYB MYBL1	1.10e-05	3	67	2	10378697
Pubmed	Septin expression in proliferative retinal membranes.	SEPTIN8 SEPTIN11	1.10e-05	3	67	2	17625225
Pubmed	Primary structure, tissue distribution, and chromosomal localization of a novel isoform of lysyl hydroxylase (lysyl hydroxylase 3).	PLOD3 PLOD1	1.10e-05	3	67	2	9582318
Pubmed	Human endothelial cell septins: SEPT11 is an interaction partner of SEPT5.	SEPTIN8 SEPTIN11	1.10e-05	3	67	2	16767699
Pubmed	MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB-NFIB fusion gene.	MYB MYBL1	1.10e-05	3	67	2	29149504
Pubmed	The lysyl hydroxylase isoforms are widely expressed during mouse embryogenesis, but obtain tissue- and cell-specific patterns in the adult.	PLOD3 PLOD1	1.10e-05	3	67	2	16996725
Pubmed	Cell cycle-coupled relocation of types I and II topoisomerases and modulation of catalytic enzyme activities.	TOP1 TOP2B	1.10e-05	3	67	2	9049244
Pubmed	The genes encoding mouse lysyl hydroxylase isoforms map to chromosomes 4,5, and 9.	PLOD3 PLOD1	1.10e-05	3	67	2	11130984
Pubmed	Characterization of cDNAs for mouse lysyl hydroxylase 1, 2 and 3, their phylogenetic analysis and tissue-specific expression in the mouse.	PLOD3 PLOD1	1.10e-05	3	67	2	10429951
Pubmed	Mammalian septins nomenclature.	SEPTIN8 SEPTIN10	1.10e-05	3	67	2	12475938
Pubmed	Identification of amino acids important for the catalytic activity of the collagen glucosyltransferase associated with the multifunctional lysyl hydroxylase 3 (LH3).	PLOD3 PLOD1	1.10e-05	3	67	2	11896059
Pubmed	Overexpression of Lewis(y) antigen protects ovarian cancer RMG-1 cells from carboplatin-induced apoptosis by the upregulation of Topo-I and Topo-II β.	TOP1 TOP2B	1.10e-05	3	67	2	21542140
Pubmed	Characterization of three fragments that constitute the monomers of the human lysyl hydroxylase isoenzymes 1-3. The 30-kDa N-terminal fragment is not required for lysyl hydroxylase activity.	PLOD3 PLOD1	1.10e-05	3	67	2	11956192
Pubmed	Nucleolin, a novel partner for the Myb transcription factor family that regulates their activity.	MYB MYBL1	1.10e-05	3	67	2	10660576
Pubmed	Glucoamylase-like domains in the alpha- and beta-subunits of phosphorylase kinase.	PHKA1 PHKA2	1.10e-05	3	67	2	12876330
Pubmed	Lysyl hydroxylase 3 is a multifunctional protein possessing collagen glucosyltransferase activity.	PLOD3 PLOD1	1.10e-05	3	67	2	10934207
Pubmed	PLODs are overexpressed in ovarian cancer and are associated with gap junctions via connexin 43.	PLOD3 PLOD1	2.19e-05	4	67	2	33483598
Pubmed	A possible implication of reduced levels of LIF, LIFR, and gp130 in vasculopathy related to systemic sclerosis.	FLI1 IL6ST	2.19e-05	4	67	2	29038846
Pubmed	Glycosylation catalyzed by lysyl hydroxylase 3 is essential for basement membranes.	PLOD3 PLOD1	2.19e-05	4	67	2	16467571
Pubmed	Cleavage of phosphorylase kinase and calcium-free calmodulin by HIV-1 protease.	PHKA1 PHKA2	2.19e-05	4	67	2	1872871
Pubmed	Isolation of cDNA clones for the catalytic gamma subunit of mouse muscle phosphorylase kinase: expression of mRNA in normal and mutant Phk mice.	PHKA1 PHKA2	2.19e-05	4	67	2	3472241
Pubmed	Temporal patterns of A-myb and B-myb gene expression during testis development.	MYB MYBL1	2.19e-05	4	67	2	8808690
Pubmed	Phosphorylase Kinase Deficiency	PHKA1 PHKA2	2.19e-05	4	67	2	21634085
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	PLOD3 DDX50 DYRK1A PAK1IP1 PLOD1 TOP2B RPS6KC1	2.24e-05	440	67	7	34244565
Pubmed	A protein interaction landscape of breast cancer.	PLOD3 DDX50 PHF19 DHPS PAK1IP1 SEPTIN10 PLOD1 TOP2B	2.96e-05	634	67	8	34591612
Pubmed	Location of phosphorylase kinase (Phk) in the mouse X chromosome.	PHKA1 PHKA2	3.64e-05	5	67	2	4726088
Pubmed	The Wnt-NLK signaling pathway inhibits A-Myb activity by inhibiting the association with coactivator CBP and methylating histone H3.	MYB MYBL1	5.46e-05	6	67	2	16055500
Pubmed	Premature aggregation of type IV collagen and early lethality in lysyl hydroxylase 3 null mice.	PLOD3 PLOD1	7.63e-05	7	67	2	15377789
Pubmed	A conserved SUMO pathway repairs topoisomerase DNA-protein cross-links by engaging ubiquitin-mediated proteasomal degradation.	TOP1 TOP2B	1.02e-04	8	67	2	33188014
Pubmed	The MYO6 interactome reveals adaptor complexes coordinating early endosome and cytoskeletal dynamics.	SEPTIN8 SEPTIN11 SEPTIN10 NOL8	1.02e-04	125	67	4	29467281
Pubmed	Superfluous role of mammalian septins 3 and 5 in neuronal development and synaptic transmission.	SEPTIN8 SEPTIN11	1.30e-04	9	67	2	18809578
Pubmed	DCHS1, Lix1L, and the Septin Cytoskeleton: Molecular and Developmental Etiology of Mitral Valve Prolapse.	SEPTIN8 SEPTIN11	1.63e-04	10	67	2	35200715
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	KNTC1 SEPTIN8 DNAH3 GINS3 SEPTIN11 IDE SEPTIN10 TOP1	2.20e-04	847	67	8	35235311
Pubmed	Mapping a dynamic innate immunity protein interaction network regulating type I interferon production.	GHITM PYGL IDE TOP1 TARBP2	2.20e-04	283	67	5	21903422
Pubmed	Chromosomal localization of opioid peptide and receptor genes in the mouse.	TOP1 MYB	2.38e-04	12	67	2	7752808
Pubmed	A protein-protein interaction map of the TNF-induced NF-κB signal transduction pathway.	MOXD1 DYRK1A HABP2 IDE PLOD1	2.97e-04	302	67	5	30561431
Pubmed	The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices.	COL12A1 PLOD3 PLOD1 ITIH5	3.11e-04	167	67	4	22159717
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	DAB2IP SEPTIN8 UBE2O NRCAM SEPTIN11 NDUFA9 SEPTIN10 LRP1B RPS6KC1	3.26e-04	1139	67	9	36417873
Pubmed	Mapping of a liver phosphorylase kinase alpha-subunit gene on the mouse X chromosome.	PHKA1 PHKA2	3.28e-04	14	67	2	8432533
Pubmed	Proteomic analysis of SRm160-containing complexes reveals a conserved association with cohesin.	SEPTIN8 DDX50 DHPS TOP2B	3.32e-04	170	67	4	16159877
Pubmed	A mouse linkage testing stock possessing multiple copies of the endogenous ecotropic murine leukemia virus genome.	CES1 MYB	4.31e-04	16	67	2	2571572
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	KNTC1 GINS3 UBE2O PAFAH1B3 DHPS SEPTIN11 PYGL IDE SEPTIN10 PLOD1	4.50e-04	1455	67	10	22863883
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	CPNE8 UBE2O PLOD3 GHITM DHPS NDUFA9 PLOD1 TARBP2 TOP2B NOL8	5.33e-04	1487	67	10	33957083
Pubmed	Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers.	CPNE8 DYRK1A LRP1B IL6ST	6.01e-04	199	67	4	23382691
Pubmed	TRIM65 regulates microRNA activity by ubiquitination of TNRC6.	UBE2O DDX50 IDE TARBP2 TOP2B	6.93e-04	364	67	5	24778252
Pubmed	Directed proteomic analysis of the human nucleolus.	DDX50 SEPTIN11 TOP1 TOP2B	7.10e-04	208	67	4	11790298
Pubmed	Characterization of definitive lymphohematopoietic stem cells in the day 9 murine yolk sac.	IL6ST MYB	8.24e-04	22	67	2	9324354
Pubmed	The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival.	GINS3 UBE2O DDX50 TOP1	8.74e-04	220	67	4	31822558
Pubmed	The treasury of the commons: making use of public gene expression resources to better characterize the molecular diversity of inhibitory interneurons in the cerebellar cortex.	CYGB GRM8 TNR	9.12e-04	98	67	3	19554387
Pubmed	Glycine N-methyltransferase-/- mice develop chronic hepatitis and glycogen storage disease in the liver.	PHKA2 PYGL	9.82e-04	24	67	2	17937387
Pubmed	NuRD subunit CHD4 regulates super-enhancer accessibility in rhabdomyosarcoma and represents a general tumor dependency.	DDX50 TOP1 TOP2B	1.05e-03	103	67	3	32744500
Pubmed	Topoisomerase IIβ Selectively Regulates Motor Neuron Identity and Peripheral Connectivity through Hox/Pbx-Dependent Transcriptional Programs.	TOP2B IL6ST	1.07e-03	25	67	2	29379870
Pubmed	The midnolin-proteasome pathway catches proteins for ubiquitination-independent degradation.	PHKA2 MOXD1 GHITM NDUFA9 TOP1 TOP2B	1.09e-03	604	67	6	37616343
Pubmed	Stage-specific changes in gene expression in acutely isolated mouse CNS progenitor cells.	SEPTIN8 LRRN1	1.15e-03	26	67	2	15890332
Pubmed	Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC-MS/MS.	SEPTIN8 SEPTIN11 SEPTIN10	1.21e-03	108	67	3	19531213
Pubmed	The level of the transcription factor Pax6 is essential for controlling the balance between neural stem cell self-renewal and neurogenesis.	GINS3 PAFAH1B3 TOP1 TOP2B	1.30e-03	245	67	4	19521500
Pubmed	FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3.	DDX50 SEPTIN11 PAK1IP1 NOL8	1.36e-03	248	67	4	27926873
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	DAB2IP SEPTIN8 SEPTIN11 NDUFA9 TNR	1.45e-03	430	67	5	32581705
Pubmed	Oxidative stress, telomere length and biomarkers of physical aging in a cohort aged 79 years from the 1932 Scottish Mental Survey.	SLC25A27 IDE NDUFA9	1.52e-03	117	67	3	18977241
Pubmed	Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry.	NRCAM TNN C8B IL6ST	1.55e-03	257	67	4	16335952
Pubmed	A genetic association analysis of cognitive ability and cognitive ageing using 325 markers for 109 genes associated with oxidative stress or cognition.	SLC25A27 IDE NDUFA9	1.60e-03	119	67	3	17601350
Pubmed	Genome-wide survey of human alternative pre-mRNA splicing with exon junction microarrays.	PHKA2 PYGL	1.64e-03	31	67	2	14684825
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	SEPTIN8 TARS3 UBE2O NRCAM DYRK1A SEPTIN11 NDUFA9 TNR TOP1	1.64e-03	1431	67	9	37142655
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	PLOD3 PAK1IP1 SEPTIN10 PLOD1 TOP1 TOP2B	1.71e-03	660	67	6	32780723
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	KNTC1 DDX50 CES1 TNN ASIC5 SEPTIN10 TOP1 TOP2B RPS6KC1	1.73e-03	1442	67	9	35575683
Pubmed	Mesenchyme-derived vertebrate lonesome kinase controls lung organogenesis by altering the matrisome.	PLOD3 PLOD1	1.75e-03	32	67	2	36920550
Pubmed	Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity.	PHKA1 PHKA2 GBP6 PLOD3 DHPS DYRK1A PLOD1	1.83e-03	910	67	7	36736316
Pubmed	Deletion of G protein-coupled receptor 48 leads to ocular anterior segment dysgenesis (ASD) through down-regulation of Pitx2.	PLOD1 MYB	1.86e-03	33	67	2	18424556
Cytoband	16q22.2	CES1 HYDIN	4.76e-04	22	67	2	16q22.2
GeneFamily	Septins	SEPTIN8 SEPTIN11 SEPTIN10	3.05e-06	13	41	3	732
GeneFamily	Fibronectin type III domain containing	COL12A1 NRCAM TNN TNR IL6ST	2.95e-05	160	41	5	555
GeneFamily	Topoisomerases	TOP1 TOP2B	7.48e-05	6	41	2	1050
GeneFamily	Fibrinogen C domain containing	TNN TNR	1.46e-03	25	41	2	554
GeneFamily	Tudor domain containing	TDRD7 PHF19	3.18e-03	37	41	2	780
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	MYB MYBL1	6.43e-03	53	41	2	532
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CPNE8 COL12A1 TLL1 ASIC5 GRM8 LRP1B	2.98e-07	179	67	6	b35a7f8115c997c390201da01d7cb10b10769aec
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SLC25A27 MOXD1 NRCAM SEPTIN11 IL6ST ITIH5	5.54e-07	199	67	6	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL12A1 TLL1 PAFAH1B3 LRP1B HYDIN	4.32e-06	160	67	5	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL12A1 TLL1 PAFAH1B3 LRP1B HYDIN	4.32e-06	160	67	5	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CPNE8 MOXD1 TARS3 TLL1 ZNF235	5.48e-06	168	67	5	32e4d82efaccf336d347e4063253c3635a3ec672
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TARS3 CYGB SEPTIN11 TNR MYBL1	6.68e-06	175	67	5	0ed053aa8353c72ff37fee830672704a3ddc7d85
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	TARS3 CYGB SEPTIN11 TNR MYBL1	6.68e-06	175	67	5	0124a3c4696b39cee8b566e94603d1d3d128bfa5
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TARS3 CYGB SEPTIN11 TNR MYBL1	6.68e-06	175	67	5	e219b61d6bc078d44ea7d06191d3462654d857a1
ToppCell	PBMC-Severe-Lymphocyte-T/NK-NK_cell-NK_CD56bright-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TARS3 CYGB SEPTIN11 TNR MYBL1	6.68e-06	175	67	5	bd16c80418bf71127e6f1e50edf83967c9218b42
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC25A27 MOXD1 NRCAM CYGB ITIH5	7.87e-06	181	67	5	9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9
ToppCell	368C-Epithelial_cells-Epithelial-F_(Ciliated)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	DNAH3 CATSPERE CES1 HYDIN MYB	8.08e-06	182	67	5	975f6275777fc578eba528e50f69891c66ec44ad
ToppCell	368C-Epithelial_cells-Epithelial-F_(Ciliated)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	DNAH3 CATSPERE CES1 HYDIN MYB	8.08e-06	182	67	5	f8c28fa76751062c4cfba0db8af1b377f947f739
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CPNE8 COL12A1 TLL1 GRM8 LRP1B	8.52e-06	184	67	5	9cc5c588f7c6631b3fb8a522214a09ca32947e72
ToppCell	P03-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CPNE8 MOXD1 TLL1 CYGB IL6ST	9.45e-06	188	67	5	5eb107122064f0a99dfd445cc87d3766f7257216
ToppCell	P07-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	CPNE8 MOXD1 TLL1 CYGB IL6ST	9.95e-06	190	67	5	e1b721bb74561fe51c53328a0394c9954e489049
ToppCell	COVID-19-Myeloid-TRAM1\|Myeloid / Condition, Lineage and Cell class	CES1 SEPTIN11 C8B ITIH5 MYB	1.07e-05	193	67	5	6e6a7f4e50c8ae70bc187b9ce77140a7049dd288
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL12A1 CYGB SEPTIN11 GRM8 ITIH5	1.07e-05	193	67	5	dd4bac8a93a5b9dcf7301f1d7d6e3eb6670f5c68
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL12A1 CYGB SEPTIN11 GRM8 ITIH5	1.07e-05	193	67	5	2ddf9b2770a0be9689e01d1a3d19e4a6d42c7a50
ToppCell	367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MOXD1 COL12A1 TNN SEPTIN11 PLOD1	1.21e-05	198	67	5	c55608633f66e3d434c5d81324efb07c5120d2c2
ToppCell	367C-Fibroblasts-Fibroblast-B_(Myofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	MOXD1 COL12A1 TNN SEPTIN11 PLOD1	1.21e-05	198	67	5	3e5459038fc6ed95f529eb4d1dc5113e16c19012
ToppCell	ILEUM-non-inflamed-(8)_Fibroblast-(8)_Fibroblasts\|(8)_Fibroblast / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	CPNE8 COL12A1 CYGB IL6ST ITIH5	1.24e-05	199	67	5	56d72da6a5fab9cbb2975fe6f87a631debaba6a8
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CPNE8 COL12A1 CYGB IL6ST ITIH5	1.27e-05	200	67	5	c5d818203bef80ff97c2e0158cf61970673dd258
ToppCell	Neuronal-Excitatory-eB(RORB)-SEMA3E-\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CPNE8 COL12A1 TLL1 GRM8 LRP1B	1.27e-05	200	67	5	1a3d29a580d1b405a74869a1da3e818c581fc559
ToppCell	Neuronal-Excitatory-eB(RORB)-SEMA3E---L4-6\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CPNE8 COL12A1 TLL1 GRM8 LRP1B	1.27e-05	200	67	5	6f9ed8fe9cda91185c3a1a675353e11b8fec6ef1
ToppCell	Neuronal-Excitatory-eB(RORB)-SEMA3E--\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CPNE8 COL12A1 TLL1 GRM8 LRP1B	1.27e-05	200	67	5	86705dfc05b3e1576543b93883c88fb55b742855
ToppCell	Neuronal-Excitatory-eB(RORB)-SEMA3E\|Neuronal / cells hierarchy compared to all cells using T-Statistic	CPNE8 COL12A1 TLL1 GRM8 LRP1B	1.27e-05	200	67	5	db194b4f524fd008b3c5b4b6014b436190a1b87a
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	SLC25A27 MOXD1 NRCAM SEPTIN11 ITIH5	1.27e-05	200	67	5	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	metastatic_Lymph_Node-Myeloid_cells-Alveolar_Mac\|Myeloid_cells / Location, Cell class and cell subclass	CES1 SEPTIN11 PNLDC1 C8B	6.08e-05	141	67	4	399380de5ea09e22fd128e3e55fffeffc4874c15
ToppCell	droplet-Lung-nan-3m-Myeloid-Proliferating_Dendritic\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KNTC1 PHF19 ZPBP GSTCD	9.92e-05	160	67	4	8a7a73b0ee1877fe02d47f745d36ae2858b529e1
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-Tnaive/CM_CD4_activated\|Liver / Manually curated celltypes from each tissue	KNTC1 SEPTIN10 IL6ST MYB	1.14e-04	166	67	4	9afa33b5ad27dc33576be592f9b22d8161366838
ToppCell	Ionocyte-iono-3\|World / Class top	KNTC1 MOXD1 TARBP2 ITIH5	1.14e-04	166	67	4	9c4a780f8af46d7552077c7a0ae0ab1b2413e5d4
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	KNTC1 LRRN1 MYB MYBL1	1.17e-04	167	67	4	50c29ea660bf07b890e4ac1a1985d0761d863dee
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L3-5_THEMIS_UBE2F\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	COL12A1 TLL1 ASIC5 GRM8	1.20e-04	168	67	4	bfa1491e8d433933003778b274710d3a16d973cb
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CPNE8 MOXD1 TLL1 IL6ST	1.22e-04	169	67	4	58136b8a0bf2dab45c91a053ef7225ea49ccb871
ToppCell	PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature\|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CPNE8 MOXD1 TLL1 IL6ST	1.22e-04	169	67	4	04c6ed38e1d1befba5ef5f37a3c1e045a0b163d6
ToppCell	PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	KNTC1 GINS3 CYGB ITIH5	1.22e-04	169	67	4	335619507857383c3b0b507cdf05d786ed59e585
ToppCell	Nasal_Brush-Epithelial-Ionocytes\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	SLC25A27 NRCAM MTARC2 ITIH5	1.31e-04	172	67	4	04fabb40fa9357d8902f3b04adc15231626cd9f8
ToppCell	Nasal_Brush-Epithelial-Ionocytes\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	SLC25A27 NRCAM MTARC2 ITIH5	1.31e-04	172	67	4	dd3a23dc78dc6939f41126f8d7bd23a2e4713647
ToppCell	367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	ZPBP TLL1 PNLDC1 MYB	1.34e-04	173	67	4	3d7c281a1a9f183a5a861d1a9c7b50d216535893
ToppCell	367C-Fibroblasts-Fibroblast-J_(Lipofibroblast)-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	ZPBP TLL1 PNLDC1 MYB	1.34e-04	173	67	4	3aa90578371039f81b7c6fa873ec70f8f2bc7dfa
ToppCell	Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4\|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	COL12A1 TLL1 ASIC5 GRM8	1.40e-04	175	67	4	06af6629766e2054e6995e8cdb3907658fec49d3
ToppCell	LPS-IL1RA+antiTNF\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC25A27 MOXD1 CES1 ITIH5	1.46e-04	177	67	4	b7fee75de7e96924af488a5baa2334711889ae7c
ToppCell	systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	DAB2IP MOXD1 LRRN1 ACY1	1.53e-04	179	67	4	021d782134126c6f7dce6b6ea50cc54bdaa39987
ToppCell	10x5'-Lung-Lymphocytic_B_plasma-Plasmablasts\|Lung / Manually curated celltypes from each tissue	KNTC1 PHF19 PAK1IP1 TARBP2	1.53e-04	179	67	4	3fa75eec3e86fd1797eaa33362257df7f9b2a0bf
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3\|368C / Donor, Lineage, Cell class and subclass (all cells)	FLI1 UBE2O ZNF235 MYBL1	1.53e-04	179	67	4	10c7d371937d9d93c12c8d3465430ef9e0c2ec81
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	COL12A1 TNN CYGB ITIH5	1.56e-04	180	67	4	f2f6e83127a4a415e65c76a35efa8175fbd5b5d9
ToppCell	E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PHKA2 SLC25A27 IDE TARBP2	1.59e-04	181	67	4	f6629fa71bb94405f523f63a9264cacf6d15c5f4
ToppCell	P03-Epithelial-airway_epithelial_cell-club_cell\|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DNAH3 TNN HYDIN MYB	1.59e-04	181	67	4	60a91587c59029a34e7bec1255083337fe21b72a
ToppCell	tumor_Lymph_Node_/_Brain-Myeloid_cells-Alveolar_Mac\|Myeloid_cells / Location, Cell class and cell subclass	CES1 C8B ITIH5 MYB	1.63e-04	182	67	4	a035d45fd512bee8dac38eb387dbf39f5a8a1fed
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-6_RORB_HPCA\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CPNE8 ASIC5 GRM8 LRP1B	1.66e-04	183	67	4	c7e94fe3e7669db9304b249979fef7a69c30a143
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL12A1 NRCAM LRP1B HYDIN	1.70e-04	184	67	4	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	normal_Lung-Fibroblasts-Myofibroblasts\|normal_Lung / Location, Cell class and cell subclass	MOXD1 COL12A1 LRRN1 TNN	1.70e-04	184	67	4	0b336489c10e8c3c957795dd845454f03404382b
ToppCell	P07-Epithelial-airway_epithelial_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DNAH3 TNN HYDIN MYB	1.70e-04	184	67	4	a5e7af3392e9d6ddad0397f1eeb6b91ed1107cc2
ToppCell	P07-Epithelial-airway_epithelial_cell-club_cell\|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DNAH3 TNN HYDIN MYB	1.70e-04	184	67	4	ab469b9e06212462cbe2e4db8775c6778db855e6
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL12A1 NRCAM LRP1B HYDIN	1.70e-04	184	67	4	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COL12A1 NRCAM LRP1B HYDIN	1.70e-04	184	67	4	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-neuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TLL1 CYGB ASIC5 GRM8	1.73e-04	185	67	4	70de48988c1f8e0809afc8092b663aa439d8e528
ToppCell	P28-Epithelial-airway_epithelial_cell-club_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DNAH3 TNN HYDIN MYB	1.77e-04	186	67	4	a26811481668fa25c48a064a56c198685693ad8d
ToppCell	Control-Endothelial-Endothelial-Artery\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CPNE8 TLL1 GRM8 LRP1B	1.77e-04	186	67	4	2d3a975d2bf92e18e3410dd413fc9f84831d82de
ToppCell	P28-Epithelial-airway_epithelial_cell\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	DNAH3 TNN HYDIN MYB	1.77e-04	186	67	4	df80f101954b8ec6ccdb03e702de22e70b65181f
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-Granular_Neuron_CB_Gabra6\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TLL1 CYGB ASIC5 GRM8	1.77e-04	186	67	4	d6c8ce2a32c218dcc63d861cc247152430ed3c8c
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	NRCAM CYGB SEPTIN11 ITIH5	1.81e-04	187	67	4	fa01a61bfd13feb033ba1e35cf513707b1bff8c8
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TLL1 CYGB ASIC5 GRM8	1.81e-04	187	67	4	7b2cd0c618ed081223343f3bec2244c8723c9a31
ToppCell	PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLI1 CPNE8 MOXD1 TLL1	1.81e-04	187	67	4	6cf7be5401b81a4eeb30840fb3733d61a24af539
ToppCell	PND01-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLI1 CPNE8 MOXD1 TLL1	1.81e-04	187	67	4	63834420db930df91b62494c9d7aaa9a25bca530
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MOXD1 NRCAM CYGB MTARC2	1.88e-04	189	67	4	e9d5e858e320c6e9913c1ea6a54967d21eda605f
ToppCell	PND10-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DNAH3 TNN HYDIN MYB	1.88e-04	189	67	4	a85099bd598a27ee64ee0664d051d89fa8d62fc9
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC25A27 MOXD1 NRCAM MTARC2	1.88e-04	189	67	4	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM1-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CES1 SEPTIN11 C8B ITIH5	1.92e-04	190	67	4	0eef5a8bd88ef8a25a67d9dd522d9472fa4b3d2f
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CES1 SEPTIN11 C8B ITIH5	1.92e-04	190	67	4	2724e8f375d8d9f5f2a77444e0491af264babac5
ToppCell	P15-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MOXD1 TLL1 CYGB IL6ST	1.92e-04	190	67	4	d072bb285bd34d518b958e7c9ad44739c60b359c
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_2\|356C / Donor, Lineage, Cell class and subclass (all cells)	CES1 SEPTIN11 C8B ITIH5	1.92e-04	190	67	4	4cce4ddb79b7751d0103e10f71156977e0c34439
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CPNE8 MOXD1 TLL1 IL6ST	1.92e-04	190	67	4	9b0ad888eb20acc011904d8593bc32bdef18d050
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM1-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CES1 SEPTIN11 C8B ITIH5	1.92e-04	190	67	4	11fbd4e9f02750354b3aadf30edc991f8d4f8f41
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MOXD1 CYGB SEPTIN11 MTARC2	1.92e-04	190	67	4	841cd55861b43578d704418b9bc0af2e8b88323a
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CES1 SEPTIN11 C8B ITIH5	1.92e-04	190	67	4	148d43dd72e2e22b2cd68e17fedae6bd98b32aee
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MOXD1 NRCAM CYGB MTARC2	1.92e-04	190	67	4	d60395739458d7f47a3350ade751fe3819500320
ToppCell	Severe_COVID-19-Myeloid-TRAM1\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	CES1 SEPTIN11 C8B ITIH5	1.96e-04	191	67	4	bd641aab36276dd952a7265ee79ba455b38d8e6b
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM3\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	CES1 SEPTIN11 C8B ITIH5	1.96e-04	191	67	4	2b10a73c5d80e83d67a7121fb004a1aa86a537ef
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM3-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CES1 SEPTIN11 C8B ITIH5	1.96e-04	191	67	4	02e1ae144da7274171e055356d10e8d175c5347f
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CPNE8 MOXD1 TLL1 IL6ST	1.96e-04	191	67	4	54bbccc554f43ba2ebdf9ea191b94c8f16081b53
ToppCell	Severe_COVID-19-Myeloid-TRAM3\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	CES1 SEPTIN11 C8B ITIH5	1.96e-04	191	67	4	05867b96199a46a415848409130697c810d18937
ToppCell	BAL-Severe-Myeloid-TRAM\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	CES1 SEPTIN11 C8B ITIH5	1.96e-04	191	67	4	4c4f50a502e3f6768a89df686fa2830b83b8b33f
ToppCell	BAL-Severe-Myeloid-TRAM\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CES1 SEPTIN11 C8B ITIH5	1.96e-04	191	67	4	de7c88bb46f794291025ef121a89fcd94dea4ffe
ToppCell	PND01-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DNAH3 TNN HYDIN MYB	1.96e-04	191	67	4	96483adb97c81208aa513782550acd8a08b63866
ToppCell	renal_papilla_nuclei-Adult_normal_reference\|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	MOXD1 COL12A1 NRCAM ITIH5	2.00e-04	192	67	4	6c106b91e46eabbe686a52a65a9c94ad9cbe9390
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM3\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CES1 SEPTIN11 C8B ITIH5	2.00e-04	192	67	4	34505a13b8a47c9286c560122fa7861b9c331a08
ToppCell	COVID-19-Myeloid-TRAM1\|COVID-19 / Condition, Lineage and Cell class	CES1 SEPTIN11 C8B ITIH5	2.00e-04	192	67	4	52b8578699325b0d35a2d3ba36772096130ccc0c
ToppCell	BAL-Severe-Myeloid-TRAM-TRAM3-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CES1 SEPTIN11 C8B ITIH5	2.00e-04	192	67	4	57c1410ebf90c230993e065eb78385daa3360960
ToppCell	3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CES1 SEPTIN11 C8B ITIH5	2.00e-04	192	67	4	fb0d05a2c83816794652a6e5af8713e9bb22d5db
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Pericyte\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	COL12A1 CYGB SEPTIN11 GRM8	2.00e-04	192	67	4	09cb5b89a164ac7444774ccc8c90323c8ea2026b
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Vein\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLI1 CPNE8 TLL1 LRP1B	2.00e-04	192	67	4	81baf1c4063469bb0c03a8602b40e387ba7b0dfb
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	CPNE8 MOXD1 TLL1 IL6ST	2.00e-04	192	67	4	c157981b9a179925edcaabc0cb3b8805f0929004
ToppCell	356C-Myeloid-Macrophage-FABP4+_Macrophage_2\|Myeloid / Donor, Lineage, Cell class and subclass (all cells)	CES1 SEPTIN11 C8B ITIH5	2.04e-04	193	67	4	aa679fb27f914a931e51cff7153861cde0edfd85
ToppCell	RV-10._Endothelium_II\|RV / Chamber and Cluster_Paper	FLI1 CPNE8 TLL1 IL6ST	2.04e-04	193	67	4	01c2df9206f1527c578e808978e58196c35e72f5
ToppCell	droplet-Bladder-nan-24m-Epithelial-bladder_mesenchymal_cell_(Car3+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MOXD1 GBP6 COL12A1 CYGB	2.04e-04	193	67	4	2d891c00b8f0aace17d4c300b63e2341dcffa199
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SLC25A27 MOXD1 NRCAM MTARC2	2.08e-04	194	67	4	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	(5)_Fibroblast-C_(Myofibroblast)\|World / Lung cell shreds - cell class (v4) and cell subclass (v4)	MOXD1 CES1 CYGB ITIH5	2.08e-04	194	67	4	29a72e565c19407bbd198cfbc2a78106fe830d05
ToppCell	TCGA-Blood_and_Bone_Marrow-Primary_Tumor-Diffuse_large_B-cell_lymphoma-DLBCL-1\|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9	DAB2IP COL12A1 TLL1 SEPTIN10	2.08e-04	194	67	4	eaeeb84576270cc3fc59002ba33bff9639bb0b02
ToppCell	11.5-Distal-Mesenchymal-Pericyte\|Distal / Age, Tissue, Lineage and Cell class	COL12A1 TNN CYGB SEPTIN11	2.08e-04	194	67	4	08701590496cf85ff790e54a81493c61177e76ff
Drug	malaoxon	MOXD1 PLOD3 CES1 PLOD1	1.25e-06	28	66	4	CID000015415
Drug	AC1NR0UN	CES1 TOP1 TOP2B	1.29e-06	8	66	3	CID005282807
Drug	A37536	TOP1 TOP2B MYB	3.78e-06	11	66	3	CID000130471
Drug	AC1L2J0B	TOP1 TOP2B	8.28e-06	2	66	2	CID000072943
Drug	methyl brevifolincarboxylate	TOP1 TOP2B	8.28e-06	2	66	2	CID005319518
Drug	cyclododecatriene	GSTCD CYGB	8.28e-06	2	66	2	CID005367375
Drug	A 62176	TOP1 TOP2B	8.28e-06	2	66	2	CID000132823
Drug	Kt 6528	TOP1 TOP2B	8.28e-06	2	66	2	CID000132714
Drug	butylethanolamine	PHKA1 PHKA2 PYGL	1.27e-05	16	66	3	CID000249006
Drug	AC1MHQTP	CYGB TOP1 TOP2B	1.84e-05	18	66	3	CID003009741
Drug	polyporenic acid C	TOP1 TOP2B	2.48e-05	3	66	2	CID005320667
Drug	paclobutrazol	TDRD7 PLOD3 PLOD1	3.95e-05	23	66	3	CID006436297
Drug	rhamnazin	IDE TOP1	4.95e-05	4	66	2	CID005320945
Drug	4-hydroxymethyl-4',5'-benzopsoralen	TOP1 TOP2B	4.95e-05	4	66	2	CID000147789
Drug	ungeremine	TOP2B MYB	4.95e-05	4	66	2	CID000159646
Drug	methylphenylcarbamate	TOP1 TOP2B	4.95e-05	4	66	2	CID000017451
Drug	mitindomide	TOP1 TOP2B	4.95e-05	4	66	2	CID000066362
Drug	2-fluoro-dATP	TOP1 TOP2B	4.95e-05	4	66	2	CID000126365
Drug	dioxazine	TOP1 TOP2B	4.95e-05	4	66	2	CID011969523
Drug	3-O-alpha-L-arabinopyranosyl-oleanolic acid	TOP1 TOP2B	4.95e-05	4	66	2	CID000124369
Drug	A-74932	TOP1 TOP2B	4.95e-05	4	66	2	CID000132825
Drug	20,29-dihydrobetulinic acid	TOP1 TOP2B	4.95e-05	4	66	2	CID000065319
Drug	tumulosic acid	TOP1 TOP2B	4.95e-05	4	66	2	CID005322174
Drug	NSC 380271	TOP1 TOP2B	4.95e-05	4	66	2	CID000342690
Drug	K00051	TOP2B IL6ST MYB MYBL1	5.41e-05	71	66	4	CID009549278
Drug	flavanone	PHKA1 PHKA2 TOP1 MYB	7.06e-05	76	66	4	CID000010251
Drug	AC1Q5O3Q	CES1 TOP1 TOP2B	8.05e-05	29	66	3	CID000368335
Drug	NSC244427	TOP1 TOP2B	8.23e-05	5	66	2	CID000316448
Drug	NSC 314622	TOP1 TOP2B	8.23e-05	5	66	2	CID000329826
Drug	2-bromo-dATP	TOP1 TOP2B	8.23e-05	5	66	2	CID000129443
Drug	3aH-benzimidazole	TOP1 TOP2B	8.23e-05	5	66	2	CID009548683
Drug	11-deoxydaunorubicin	TOP1 TOP2B	8.23e-05	5	66	2	CID000158483
Drug	4-demethoxy-11-deoxy-4'-epi-daunorubicin	TOP1 TOP2B	8.23e-05	5	66	2	CID000158476
Drug	coralyne	TOP1 TOP2B	8.23e-05	5	66	2	CID000023306
Drug	AC1L43MI	TOP1 TOP2B	8.23e-05	5	66	2	CID000150081
Drug	NSC622082	TOP1 TOP2B	8.23e-05	5	66	2	CID000494392
Drug	elomotecan	TOP1 TOP2B	8.23e-05	5	66	2	CID000216300
Drug	4-demethyl-6-O-methyldoxorubicin	TOP1 TOP2B	8.23e-05	5	66	2	CID000126902
Drug	dehydro-histidinohydroxymerodesmosine	PLOD3 PLOD1	8.23e-05	5	66	2	CID003037599
Drug	eupolauridine	TOP1 TOP2B	8.23e-05	5	66	2	CID000072486
Drug	AC1L9MFU	PHKA1 PHKA2 PLOD3 PLOD1	9.50e-05	82	66	4	CID000448874
Drug	mannose-1-phosphate	PHKA1 PHKA2 PYGL IL6ST MYB	1.18e-04	165	66	5	CID000000466
Drug	intoplicine	TOP1 TOP2B	1.23e-04	6	66	2	CID000065954
Drug	DMP 840	TOP1 TOP2B	1.23e-04	6	66	2	CID000060916
Drug	BE-10988	TOP1 TOP2B	1.23e-04	6	66	2	CID000126200
Drug	galbacin	TOP1 TOP2B	1.23e-04	6	66	2	CID000234441
Drug	pyridinium formate	PLOD3 PLOD1	1.23e-04	6	66	2	CID013326228
Drug	UCE6	TOP1 TOP2B	1.23e-04	6	66	2	CID000127735
Drug	berberrubine	TOP1 TOP2B	1.23e-04	6	66	2	CID000072703
Drug	saintopin	TOP1 TOP2B	1.23e-04	6	66	2	CID000131350
Drug	AC1L8YYB	CES1 TOP1 TOP2B	1.31e-04	34	66	3	CID000435167
Drug	Cytosar-U	CES1 CYGB PYGL TOP1 TOP2B IL6ST MYB	1.54e-04	399	66	7	CID000000596
Drug	AC1Q5ZRG	FLI1 TOP1 TOP2B	1.55e-04	36	66	3	CID000004526
Drug	PCMB	CES1 CYGB PYGL IDE ACY1	1.68e-04	178	66	5	CID000001730
Drug	NBQCl	TOP1 TOP2B	1.72e-04	7	66	2	CID000134086
Drug	nogalose	TOP1 TOP2B	1.72e-04	7	66	2	CID000161660
Drug	nitidine	TOP1 TOP2B	1.72e-04	7	66	2	CID000004501
Drug	tBCEU	GSTCD TOP2B	2.29e-04	8	66	2	CID000164059
Drug	7-OMEN	TOP1 TOP2B	2.29e-04	8	66	2	CID000051370
Drug	coumalic acid	PLOD3 PLOD1	2.29e-04	8	66	2	CID000068141
Drug	batracylin	TOP1 TOP2B	2.29e-04	8	66	2	CID000071750
Drug	AC1N0FHX	GSTCD TOP2B	2.29e-04	8	66	2	CID003916227
Drug	HHMD	PLOD3 PLOD1	2.29e-04	8	66	2	CID000171068
Drug	hydroxyallysine	PLOD3 PLOD1	2.29e-04	8	66	2	CID000153008
Drug	9-HME	TOP1 TOP2B	2.29e-04	8	66	2	CID003034753
Drug	AC1L33JB	GSTCD TOP2B	2.29e-04	8	66	2	CID000108202
Drug	CPD-7231	IDE MYB	2.29e-04	8	66	2	CID003085404
Drug	Bis-netropsin	TOP1 TOP2B	2.29e-04	8	66	2	CID000482856
Drug	NSC-294410	TOP1 TOP2B	2.29e-04	8	66	2	CID000457914
Drug	ICI 182,780; Down 200; 1uM; MCF7; HG-U133A	PHKA2 DNAH3 PAK1IP1 IL6ST MYBL1	2.38e-04	192	66	5	367_DN
Drug	ardisin	TOP1 TOP2B	2.94e-04	9	66	2	CID000417291
Drug	trimethylthiophosphate	CES1 GSTCD	2.94e-04	9	66	2	CID000009038
Drug	IST-622	TOP1 TOP2B	2.94e-04	9	66	2	CID003081749
Drug	orthanilic acid	GSTCD PLOD1	2.94e-04	9	66	2	CID000006926
Drug	o-AMSA	TOP1 TOP2B	2.94e-04	9	66	2	CID000107747
Drug	oxolinic acid	TNN TOP1 TOP2B	3.03e-04	45	66	3	CID000004628
Drug	T694	DDX50 TNN PYGL MYBL1	3.38e-04	114	66	4	CID000000872
Drug	tetrabutylammonium	GSTCD PLOD1 TOP1	3.44e-04	47	66	3	CID000016027
Drug	di-fluoro	PLOD3 PLOD1 TOP1	3.67e-04	48	66	3	CID000069610
Drug	benzoquinone mustard	GSTCD TOP2B	3.67e-04	10	66	2	CID000150975
Drug	nitracrine	ACY1 TOP1	3.67e-04	10	66	2	CID000020628
Drug	5-oxaproline	PLOD3 PLOD1	3.67e-04	10	66	2	CID003082452
Drug	tungsten oxide	MOXD1 TNN	3.67e-04	10	66	2	CID000014811
Drug	AC1MZ4R5	TOP1 TOP2B	3.67e-04	10	66	2	CID003842392
Disease	glycogen storage disease (is_implicated_in)	PHKA1 PHKA2 PYGL	9.31e-07	9	67	3	DOID:2747 (is_implicated_in)
Disease	Glycogen phosphorylase kinase deficiency	PHKA1 PHKA2	3.04e-05	4	67	2	cv:C0268147
Disease	maleate measurement, Alpha ketoglutarate measurement, fumarate measurement	GHITM GRM8	2.76e-04	11	67	2	EFO_0010457, EFO_0010480, EFO_0010509
Disease	Glycogen storage disease	PHKA1 PHKA2	6.76e-04	17	67	2	cv:C0017919
Disease	Astrocytosis	GRM8 TNR	6.76e-04	17	67	2	C3887640
Disease	Gliosis	GRM8 TNR	6.76e-04	17	67	2	C0017639
Disease	Corneal astigmatism	FLI1 PHF19 TNR	7.26e-04	77	67	3	EFO_1002040
Disease	Glycogen Storage Disease	PHKA2 PYGL	1.72e-03	27	67	2	C0017919
Disease	eosinophil count	SEPTIN8 FLI1 DNAH3 C6orf89 ZPBP DYRK1A HABP2 PLOD1 GK5 MYB	1.86e-03	1488	67	10	EFO_0004842

Protein segments in the cluster

Peptide	Gene	Start	Entry
ENVVVVTIQYRLGIW	CES1	161	P23141
KGEALTVWTQIVYPE	CATSPERE	601	Q5SY80
GQVVKAYDRVEQEWV	DYRK1A	171	Q13627
HIRPKIVVVWVGTNN	PAFAH1B3	91	Q15102
ELVQRKRVGVWNVPY	PLOD3	446	O60568
VAGRQFVEKWYPVVT	DAB2IP	301	Q5VWQ8
AWGIRIYQKRTQPTV	LRP1B	456	Q9NZR2
VYGEPRELLTKVWVQ	MAGEC2	266	Q9UBF1
VPVVWKQRKIYNGEE	ITIH5	886	Q86UX2
TWIVKQPEYAVVQRG	NRCAM	546	Q92823
EIGAIEKAVIWPQYV	GHITM	106	Q9H3K2
NPEDVQEIIVWKRYS	RPS6KC1	41	Q96S38
RVPVGFYQKVWKVLQ	PHKA1	1066	P46020
VVYQIEGSKAVPWVI	CANT1	186	Q8WVQ1
VPYFSKAWQRVIQIP	KNTC1	2011	P50748
RIEQDYWQVPRKGVK	GBP6	441	Q6ZN66
QRVIELVQKYGPKRW	MYB	101	P10242
YRVETVKPGKIVWQE	NOL8	1061	Q76FK4
WGSKIAPVYQQEEIA	GRM8	311	O00222
LGWKTVKQPVYVVDV	NDUFA9	231	Q16795
DIVQGRRVGVWNVPY	PLOD1	436	Q02809
RPGVYTQVTKFLNWI	HABP2	536	Q14520
KQILNVWAYPTSVGV	HYDIN	2891	Q4G0P3
TQGYRTVQLVWKTLP	IL6ST	341	P40189
IWQITDRDYKPQVGV	COL12A1	2596	Q99715
HWQQISEIVGYEIKP	DNAH3	956	Q8TD57
SWGKIRVDAQPVKVY	DHPS	326	P49366
YKEVGWVQQVPNATT	CYGB	166	Q8WWM9
EWINQPVRVNVKREY	FLI1	56	Q01543
WSQRPAVIGDVLQVY	DDX50	371	Q9BQ39
VTIRQVKTVHQEYPW	ASIC5	281	Q9NY37
LQQVGTVAKLWIYPV	MTARC2	51	Q969Z3
SVQKVENLYPQIGWV	GK5	46	Q6ZS86
QYIQKLRAEGPQEWV	IDE	396	P14735
TTHWKVYVIARGVQP	C6orf89	321	Q6UWU4
ASWYQRIQEVPGVKT	GSTCD	316	Q8NEC7
EWGDAVQYNPAIIKV	C8B	451	P07358
PICVLYVQGVGNKEW	CPNE8	46	Q86YQ8
QRVIELVQKYGPKRW	MYBL1	96	P10243
KRTVIEQQPVLWYVF	GGT2P	181	P36268
AINRVPVGFYQRVWK	PHKA2	1076	P46019
EIYWVTPIGNKITVE	LRRN1	456	Q6UXK5
TVQGEVWKTTPYQVA	TARS3	171	A2RTX5
VLQVVQWKSEATPYR	TMEM179B	181	Q7Z7N9
THVQIYVPWILQQVG	PRSS29P	296	A6NIE9
KARQYPWGVVQVENE	SEPTIN11	251	Q9NVA2
ELPVRTWTQVYKEQV	TOP2B	946	Q02880
VELPKIYQEGWRTVF	GINS3	86	Q9BRX5
WQVVAPTQYRISVKF	TLL1	646	O43897
SVKRWPGVSEQQVYH	PNLDC1	426	Q8NA58
VIENANPWDRKVVVY	TDRD7	1056	Q8NHU6
KVEVAPGYVVTVLTW	ACY1	51	Q03154
QFIGVKEIYRPVTTW	MOXD1	491	Q6UVY6
RPGVEYTVHVWAQKG	TNN	591	Q9UQP3
YLVAWQPVVIGIVQG	RNF175	306	Q8N4F7
LQWKAPVGEVENYVI	TNR	971	Q92752
YVRVQWYPEGVKQHV	UBE2O	121	Q9C0C9
KLWQGVTPAIYRHVV	SLC25A27	86	O95847
RVTPEGKVQYLVEWE	PHF19	561	Q5T6S3
KLVRARQYPWGVVQV	SEPTIN8	251	Q92599
EWSPRGEQYVVIIQN	PAK1IP1	171	Q9NWT1
KARQYPWGVVQVENE	SEPTIN10	276	Q9P0V9
QWYGPKGKVVSVENR	ZPBP	101	Q9BS86
ELVVQKGWRLPEYTV	TARBP2	166	Q15633
RTIKEYAQNIWNVEP	PYGL	816	P06737
IPVQQSVRTGKKRYW	ZNF235	306	Q14590
WGVPIEKIYNKTQRE	TOP1	736	P11387